What is NDC 60290-009?

60290-009 is the product NDC for Olmesartan Medoxomil, Olmesartan medoxomil 5 mg/1 tablet, listed with the FDA by Umedica Laboratories USA Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

Umedica Laboratories USA Inc., NDC labeler code 60290. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Olmesartan Medoxomil?

122 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Olmesartan Medoxomil NDC 60290-009

NDC codes

FDA NDC Directory

Product NDC (as listed)60290-009Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60290-0009Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
60290-009-01	6029000090160290000901	30 TABLET in 1 BOTTLE (60290-009-01)Marketed from Feb 15, 2026
60290-009-02	6029000090260290000902	90 TABLET in 1 BOTTLE (60290-009-02)Marketed from Feb 15, 2026
60290-009-03	6029000090360290000903	10 TABLET in 1 BLISTER PACK (60290-009-03)Marketed from Feb 15, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Olmesartan Medoxomil
Generic name (nonproprietary): olmesartan medoxomil
Active ingredients: Olmesartan medoxomil — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Umedica Laboratories USA Inc.NDC labeler code 60290
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207135
Marketing start: Feb 15, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 60290-009_5cace4b6-59fc-195e-e063-6394a90aced7SPL ID 5cace4b6-59fc-195e-e063-6394a90aced7
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460290000901 followed by a unit qualifier and the quantity

Package 60290-0009-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 60290-009

What is NDC 60290-009?: 60290-009 is the product NDC for Olmesartan Medoxomil, Olmesartan medoxomil 5 mg/1 tablet, listed with the FDA by Umedica Laboratories USA Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Olmesartan Medoxomil.
What is the active ingredient?: Olmesartan medoxomil.
Who is the labeler?: Umedica Laboratories USA Inc., NDC labeler code 60290. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Olmesartan Medoxomil?: 122 other product NDCs are listed under this name. See all Olmesartan Medoxomil NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Olmesartan Medoxomil NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Olmesartan medoxomil	Olmesartan medoxomil 5 mg/1	TabletOral	NorthStar RxLLC	72603-950	72603-0950-0172603-0950-02
Olmesartan medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	NorthStar RxLLC	72603-951	72603-0951-0172603-0951-02
Olmesartan medoxomil	Olmesartan medoxomil 40 mg/1	TabletOral	NorthStar RxLLC	72603-952	72603-0952-0172603-0952-02
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0848	72303-0848-0172303-0848-02
Olmesartan Medoxomil	Olmesartan medoxomil 20 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0849	72303-0849-0172303-0849-02
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0850	72303-0850-0172303-0850-02
Olmesartan medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	REMEDYREPACK INC.	70518-4598	70518-4598-00
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-011	60290-0011-0160290-0011-0260290-0011-03
Olmesartan Medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-010	60290-0010-0160290-0010-0260290-0010-03
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	Tablet, Film coatedOral	Direct_Rx	72189-660	72189-0660-3072189-0660-90

All 123 Olmesartan Medoxomil NDCs

Other NDCs under ANDA 207135

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207135
Product	Strength	Form · route	Labeler	Product NDC
Olmesartan Medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-010
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-011
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	TabletOral	Lifestar Pharma LLC	70756-808
Olmesartan Medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	Lifestar Pharma LLC	70756-809
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	TabletOral	Lifestar Pharma LLC	70756-810